GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

UUU · Jun 30, 2024

UNIVERSAL SAFETY PRODUCTS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001410578-24-001526General Corporate
Operating cash generation8thOwn-history percentile · N=13
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-26.05% · OPTIONAL · VALID

Revenue growth9thOwn-history percentile · N=11
Evidence method

Yoy · gp.fundamentals.revenue

-31.35% · CORE · VALID

Inventory pressure85thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

111.05% · OPTIONAL · VALID

Gross margin0thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.gross_margin

23.65% · CORE · VALID

Operating margin0thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.operating_margin

-8.64% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History24 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
3.04%
Current
-26.05%
Delta
-29.09%
Growth Decreased
Previous
-10.26%
Current
-31.35%
Delta
-21.09%
Margin Decreased
Previous
29.18%
Current
23.65%
Delta
-5.53%
Profitability Decreased
Previous
-1.33%
Current
-8.64%
Delta
-7.31%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.